Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)-Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q).
Rüfer A, Angermann H, Benz R, Bonadies N, Calderoni A, Cantoni N, Efthymiou A, Escher R, Favre G, Friess D, Gschwend A, Himmelmann A, Holbro A, Keller P, Kouroupi E, Lehmann T, Pedarnig N, Rigamonti V, Samii K, Schmidt A, Schäfer HP, Sperb R, Stüssi G, Winkler A, Zenhäusern R, Goede JS. Rüfer A, et al. Among authors: zenhausern r. Hemasphere. 2022 Jun 17;6(7):e741. doi: 10.1097/HS9.0000000000000741. eCollection 2022 Jul. Hemasphere. 2022. PMID: 35747588 Free PMC article. No abstract available.
Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study.
Rothschild SI, Betticher D, Zenhäusern R, Anchisi S, von Moos R, Pless M, Moosmann P, Popescu RA, Calderoni A, Dressler M, Rauch D, Pederiva S, Woelky R, Papet C, Bühler V, Borner M. Rothschild SI, et al. Among authors: zenhausern r. Cancer Chemother Pharmacol. 2019 Oct;84(4):881-889. doi: 10.1007/s00280-019-03927-x. Epub 2019 Aug 23. Cancer Chemother Pharmacol. 2019. PMID: 31444619 Free PMC article.
Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02).
Leupin N, Schuller JC, Solenthaler M, Heim D, Rovo A, Beretta K, Gregor M, Bargetzi MJ, Brauchli P, Himmelmann A, Hanselmann S, Zenhäusern R. Leupin N, et al. Among authors: zenhausern r. Leuk Lymphoma. 2010 Apr;51(4):613-9. doi: 10.3109/10428191003624231. Leuk Lymphoma. 2010. PMID: 20218808 Clinical Trial.
Quality of Life in Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer Using Cabazitaxel or Other Therapies After Previous Docetaxel Chemotherapy: Swiss Observational Treatment Registry.
Stenner F, Rothschild SI, Betticher D, Caspar C, Morant R, Popescu R, Rauch D, Huber U, Zenhäusern R, Rentsch C, Cathomas R. Stenner F, et al. Among authors: zenhausern r. Clin Genitourin Cancer. 2017 Aug 24:S1558-7673(17)30244-6. doi: 10.1016/j.clgc.2017.08.003. Online ahead of print. Clin Genitourin Cancer. 2017. PMID: 28958629
Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia: a multicentre trial SAKK 32/95.
Zenhäusern R, Von Rohr A, Rufibach K, Solenthaler M, Meyer-Monard S, Gratwohl A, Hess U, Bargetzi MJ, Kovacsovic T, Leoncini L, Tobler A; Swiss Group for Clinical Cancer Research (SAKK). Zenhäusern R, et al. Leuk Lymphoma. 2009 Jan;50(1):133-6. doi: 10.1080/10428190802527681. Leuk Lymphoma. 2009. PMID: 19152171 Clinical Trial. No abstract available.
53 results